Literature DB >> 23141492

High-density lipoproteins: from function to therapy.

Chunyu Zheng, Masanori Aikawa.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23141492     DOI： 10.1016/j.jacc.2012.08.999

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  16 in total

1.  Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.

Authors:  Hamid Moradi; Elani Streja; Moti L Kashyap; Nosratola D Vaziri; Gregg C Fonarow; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

2.  AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.

Authors:  Soo-Ho Choi; Aaron M Wallace; Dina A Schneider; Elianne Burg; Jungsu Kim; Elena Alekseeva; Niki Dj Ubags; Carlyne D Cool; Longhou Fang; Benjamin T Suratt; Yury I Miller
Journal:  JCI Insight       Date:  2018-08-23

Review 3.  Unbiased and targeted mass spectrometry for the HDL proteome.

Authors:  Sasha A Singh; Masanori Aikawa
Journal:  Curr Opin Lipidol       Date:  2017-02       Impact factor: 4.776

4.  High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy.

Authors:  Samia Mora; Robert J Glynn; Paul M Ridker
Journal:  Circulation       Date:  2013-09-03       Impact factor: 29.690

5.  Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids.

Authors:  Jason W Castle; Kevin P Kent; Ying Fan; Kirk D Wallace; Cynthia E L Davis; Jeannette C Roberts; Michael E Marino; Kai E Thomenius; Hae W Lim; Eric Coles; Michael H Davidson; Steven B Feinstein; Anthony DeMaria
Journal:  Atherosclerosis       Date:  2015-05-05       Impact factor: 5.162

6.  Multiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoring.

Authors:  Sasha A Singh; Allison B Andraski; Brett Pieper; Wilson Goh; Carlos O Mendivil; Frank M Sacks; Masanori Aikawa
Journal:  J Lipid Res       Date:  2016-02-09       Impact factor: 5.922

7.  Automation of PRM-dependent D3-Leu tracer enrichment in HDL to study the metabolism of apoA-I, LCAT and other apolipoproteins.

Authors:  Lang Ho Lee; Allison B Andraski; Brett Pieper; Hideyuki Higashi; Frank M Sacks; Masanori Aikawa; Sasha A Singh
Journal:  Proteomics       Date:  2017-01       Impact factor: 3.984

Review 8.  Regulation of lipid rafts, angiogenesis and inflammation by AIBP.

Authors:  Longhou Fang; Yury I Miller
Journal:  Curr Opin Lipidol       Date:  2019-06       Impact factor: 4.776

9.  HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

Authors:  Günther Silbernagel; Bernd Genser; Christiane Drechsler; Hubert Scharnagl; Tanja B Grammer; Tatjana Stojakovic; Vera Krane; Eberhard Ritz; Christoph Wanner; Winfried März
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

10.  Lipid-modulating treatments for mixed dyslipidemia increase HDL-associated phospholipase A2 activity with differential effects on HDL subfractions.

Authors:  Anastazia Kei; Evangelos Liberopoulos; Costantinos Tellis; Moses Elisaf; Alexandros Tselepis
Journal:  Lipids       Date:  2013-08-15       Impact factor: 1.880
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.